Community-associated Clostridium difficile infections, Monroe county, New York, USA

Emerging Infectious Diseases

Volumn 18, Issue 3, 2012, Pages 392-400

  Dumyati, Ghinwa ^a   Stevens, Vanessa ^a,b   Hannett, George E ^c   Thompson, Angela D ^d   Long, Cherie ^d   Maccannell, Duncan ^d   Limbago, Brandi ^d  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; HISTAMINE H2 RECEPTOR ANTAGONIST; MACROLIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNICABLE DISEASE; CONTROLLED STUDY; FECES CULTURE; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PROGNOSIS; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SENTINEL SURVEILLANCE; STRAIN DIFFERENCE; UNITED STATES;

ADULT; AGED; CLOSTRIDIUM DIFFICILE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEW YORK; SENTINEL SURVEILLANCE;

EID: 84857543395     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1803.102023     Document Type: Article

References (40)

1. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23:529-49. http://dx.doi.org/10.1128/CMR.00082-09
2. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis. 2008;14:929-31. http://dx.doi.org/10.3201/eid1406.071447
3. Kuijper EJ, Wilcox MH. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection? Clin Infect Dis. 2008;47:63-5. http://dx.doi.org/10.1086/588294
4. Centers for Disease Control and Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1201-5.
5. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433-41. http://dx.doi.org/10.1056/NEJMoa051590
6. Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fl uoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254-60. http://dx.doi.org/10.1086/496986
7. Gould LH, Limbago B. Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis. 2010;51:577-82. http://dx.doi.org/10.1086/655692
8. Limbago BM, Long CM, Thompson AD, Killgore GE, Hannett GE, Havill NL, et al. Clostridium difficile strains from community-associated infections. J Clin Microbiol. 2009;47:3004-7. http://dx.doi.org/10.1128/JCM.00964-09
9. Kutty PK, Woods CW, Sena AC, Benoit SR, Naggie S, Frederick J, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis. 2010;16:197-204.
10. Bauer MP, Veenendaal D, Verhoef L, Bloembergen P, van Dissel JT, Kuijper EJ. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in the Netherlands. Clin Microbiol Infect. 2009;15:1087-92. http://dx.doi.org/10.1111/j.1469-0691.2009.02853.x
11. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294:2989-95. http://dx.doi.org/10.1001/jama.294.23.2989
12. Delaney JA, Dial S, Barkun A, Suissa S. Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis. 2007;13:761-3.
13. Centers for Disease Control and Prevention. Surveillance for community-associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008;57:340-3.
14. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62:388-96. http://dx.doi.org/10.1093/jac/dkn163
15. Rodriguez-Palacios A, Staempfli HR, Duffield T, Weese JS. Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis. 2007;13:485-7. http://dx.doi.org/10.3201/eid1303.060988
16. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis. 2009;15:819-21. http://dx.doi.org/10.3201/eid1505.081071
17. Metcalf DS, Costa MC, Dew WM, Weese JS. Clostridium difficile in vegetables, Canada. Lett Appl Microbiol. 2010;51:600-2. http://dx.doi.org/10.1111/j.1472-765X.2010.02933.x
18. Metcalf D, Reid-Smith RJ, Avery BP, Weese JS. Prevalence of Clostridium difficile in retail pork. Can Vet J. 2010;51:873-6.
19. Weese JS, Reid-Smith RJ, Avery BP, Rousseau J. Detection and characterization of Clostridium difficile in retail chicken. Lett Appl Microbiol. 2010;50:362-5. http://dx.doi.org/10.1111/j.1472-765X.2010.02802.x
20. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28:140-5. http://dx.doi.org/10.1086/511798
21. George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol. 1979;9:214-9.
22. Arroyo LG, Rousseau J, Willey BM, Low DE, Staempfli H, Mc-Geer A, et al. Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions. J Clin Microbiol. 2005;43:5341-3. http://dx.doi.org/10.1128/JCM.43.10.5341-5343.2005
23. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmee M. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol. 1998;36:2240-7.
24. Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E, Pepin J, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-fi eld gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplifi ed fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol. 2008;46:431-7. http://dx.doi.org/10.1128/JCM.01484-07
25. Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard. 7th edition. CLSI document M11-A7. Wayne (PA): The Institute; 2007.
26. Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, Warny M, et al. Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis. 2008;14:1039-45. http://dx.doi.org/10.3201/eid1407.071641
27. Stergachis A, Perera DR, Schnell MM, Jick H. Antibiotic-associated colitis. West J Med. 1984;140:217-9.
28. Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis. 1994;169:127-33. http://dx.doi.org/10.1093/infdis/169.1.127
29. Levy DG, Stergachis A, McFarland LV, Van Vorst K, Graham DJ, Johnson ES, et al. Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting. Clin Ther. 2000;22:91-102. http://dx.doi.org/10.1016/S0149-2918(00)87980-1
30. Norén T, Akerlund T, Back E, Sjoberg L, Persson I, Alriksson I, et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol. 2004;42:3635-43. http://dx.doi.org/10.1128/JCM.42.8.3635-3643.2004
31. Naggie S, Frederick J, Pien BC, Miller BA, Provenzale DT, Goldberg KC, et al. Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA. Infection. 2010;38:297-300. http://dx.doi.org/10.1007/s15010-010-0025-0
32. Karlström O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile study group. Clin Infect Dis. 1998;26:141-5.
33. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008;179:767-72. http://dx.doi.org/10.1503/cmaj.071812
34. Naggie S, Miller BA, Zuzak KB, Pence BW, Mayo AJ, Nicholson BP, et al. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med. 2011;124:276.e1-7. http://dx.doi.org/10.1016/j.amjmed.2010.10.013
35. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294:2989-95. http://dx.doi.org/10.1001/jama.294.23.2989
36. Bignardi GE, Settle C. Different ribotypes in community-acquired Clostridium difficile. J Hosp Infect. 2008;70:96-8. http://dx.doi.org/10.1016/j.jhin.2008.04.003
37. MacCannell DR, Louie TJ, Gregson DB, Laverdiere M, Labbe AC, Laing F, et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from eastern and western Canada. J Clin Microbiol. 2006;44:2147-52. http://dx.doi.org/10.1128/JCM.02563-05
38. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079-84. http://dx.doi.org/10.1016/S0140-6736(05)67420-X
39. Otten AM, Reid-Smith RJ, Fazil A, Weese JS. Disease transmission model for community-associated Clostridium difficile infection. Epidemiol Infect. 2010;138:907-14. http://dx.doi.org/10.1017/S0950268809991646
40. Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, Breathnach A, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis. 2008;8:777-84. http://dx.doi.org/10.1016/S1473-3099(08)70233-0